These early guidelines did not set specific thresholds for genetic testing but, emphasised the importance of testing high risk individuals with cancer to open the possibility of testing for BRCA1, BRCA2 and Lynch syndrome genes [2, 3]. The gene discussed is BRCA1; the disease is Lynch syndrome.